A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy (Q125889752)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy |
scientific article published in 2022 |
Statements
A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy (English)
Dong Liu
Xuexiu Qi
Xiaoyi Wei
Lijun Zhao
Xuechun Wang
Shuhong Li
Zhidong Wang
Licai Shi
Jiean Xu
Mei Hong
Zhong Liu
Lili Zhao
Xiankun Wang
Bo Zhang
Yuhan Zhang
Feng Wang
Yu J. Cao
2022
12
18
7788-7803